Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	61.58	37.43	42.45	53.36	49.07
Short-Term Investments	314.07	0	0	0	0
Cash & Cash Equivalents	375.65	37.43	42.45	53.36	49.07
Cash Growth	903.57%	-11.81%	-20.45%	8.74%	486.76%
Other Current Assets	1.22	0.16	0.25	1.06	0.9
Total Current Assets	376.87	37.59	42.7	54.42	49.97
Property, Plant & Equipment	1.04	0.26	0.37	0.49	0.45
Long-Term Investments	18.07	0	0	0	0
Other Long-Term Assets	0.04	0.01	0.02	0.02	0.01
Total Long-Term Assets	19.15	0.27	0.39	0.5	0.46
Total Assets	396.02	37.86	43.09	54.92	50.43
Accounts Payable	3.46	0.36	0.33	1.12	1.77
Current Debt	0.21	0	0	0	0
Other Current Liabilities	9.37	0.28	0.8	2.38	1.73
Total Current Liabilities	13.04	0.64	1.13	3.5	3.5
Long-Term Debt	0.76	0.2	0.28	0.38	0.41
Total Long-Term Liabilities	0.76	0.2	0.28	0.38	0.41
Total Liabilities	13.8	0.84	1.41	3.88	3.91
Total Debt	0.97	0.2	0.28	0.38	0.41
Debt Growth	374.51%	-27.14%	-26.89%	-6.36%	-
Retained Earnings	-83.72	-188.74	-183.4	-173.48	-154.15
Comprehensive Income	-0.04	0	0	0	0
Shareholders' Equity	382.22	37.02	41.67	51.04	46.52
Net Cash / Debt	374.68	37.23	42.17	52.98	48.66
Net Cash / Debt Growth	906.47%	-11.71%	-20.41%	8.87%	481.87%
Net Cash Per Share	22.32	30.99	35.11	45.72	123.97
Working Capital	363.83	36.96	41.57	50.92	46.47
Book Value Per Share	22.77	30.82	34.70	44.05	118.52

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).